As of 2024-07-27, the Relative Valuation of Eli Lilly and Co (LLY) is 196.80 USD. This relative valuation is based on P/E multiples. With the latest stock price at 804.62 USD, the upside of Eli Lilly and Co based on Relative Valuation is -75.5%.
The range of the Relative Valuation is 145.71 - 238.07 USD.
| Range | Selected | |
| Trailing P/E multiples | 30.8x - 36.9x | 32.8x |
| Forward P/E multiples | 20.6x - 30.5x | 25.6x |
| Fair Price | 145.71 - 238.07 | 196.80 |
| Upside | -81.9% - -70.4% | -75.5% |
| Date | P/E |
| 2024-07-26 | 124.58 |
| 2024-07-25 | 127.15 |
| 2024-07-24 | 133.14 |
| 2024-07-23 | 135.99 |
| 2024-07-22 | 134.08 |
| 2024-07-19 | 132.76 |
| 2024-07-18 | 131.44 |
| 2024-07-17 | 140.21 |
| 2024-07-16 | 145.79 |
| 2024-07-15 | 147.16 |
| 2024-07-12 | 146.84 |
| 2024-07-11 | 144.63 |
| 2024-07-10 | 145.51 |
| 2024-07-09 | 144.38 |
| 2024-07-08 | 142.13 |
| 2024-07-05 | 141.60 |
| 2024-07-03 | 139.05 |
| 2024-07-02 | 140.39 |
| 2024-07-01 | 141.57 |
| 2024-06-28 | 140.18 |
| 2024-06-27 | 140.75 |
| 2024-06-26 | 139.54 |
| 2024-06-25 | 140.06 |
| 2024-06-24 | 137.82 |
| 2024-06-21 | 136.85 |
| 2024-06-20 | 137.18 |
| 2024-06-18 | 138.02 |
| 2024-06-17 | 137.03 |
| 2024-06-14 | 136.01 |
| 2024-06-13 | 136.77 |
| 2024-06-12 | 134.28 |
| 2024-06-11 | 134.06 |
| 2024-06-10 | 133.93 |
| 2024-06-07 | 131.60 |
| 2024-06-06 | 129.64 |
| 2024-06-05 | 128.78 |
| 2024-06-04 | 128.91 |
| 2024-06-03 | 128.70 |
| 2024-05-31 | 127.01 |
| 2024-05-30 | 126.20 |
| 2024-05-29 | 125.65 |
| 2024-05-28 | 125.08 |
| 2024-05-24 | 125.01 |
| 2024-05-23 | 125.17 |
| 2024-05-22 | 124.31 |
| 2024-05-21 | 124.36 |
| 2024-05-20 | 121.26 |
| 2024-05-17 | 119.22 |
| 2024-05-16 | 119.39 |
| 2024-05-15 | 121.85 |